- Home
- APLM vs SSY Comparison
APLM vs SSY Comparison
Compare APLM & SSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- SSY
- Stock Information
- Founded
- APLM 2016
- SSY 1959
- Country
- APLM United States
- SSY United States
- Employees
- APLM N/A
- SSY N/A
- Industry
- APLM Blank Checks
- SSY Hospital/Nursing Management
- Sector
- APLM Finance
- SSY Health Care
- Exchange
- APLM Nasdaq
- SSY Nasdaq
- Market Cap
- APLM 6.5M
- SSY 6.3M
- IPO Year
- APLM N/A
- SSY N/A
- Fundamental
- Price
- APLM $5.68
- SSY $0.91
- Analyst Decision
- APLM Strong Buy
- SSY
- Analyst Count
- APLM 1
- SSY 0
- Target Price
- APLM $200.00
- SSY N/A
- AVG Volume (30 Days)
- APLM 25.0K
- SSY 8.6K
- Earning Date
- APLM 04-03-2025
- SSY 05-19-2025
- Dividend Yield
- APLM N/A
- SSY N/A
- EPS Growth
- APLM N/A
- SSY N/A
- EPS
- APLM N/A
- SSY 0.14
- Revenue
- APLM $198,000.00
- SSY $31,233,000.00
- Revenue This Year
- APLM $415.15
- SSY N/A
- Revenue Next Year
- APLM N/A
- SSY N/A
- P/E Ratio
- APLM N/A
- SSY $6.30
- Revenue Growth
- APLM N/A
- SSY N/A
- 52 Week Low
- APLM $4.71
- SSY $0.53
- 52 Week High
- APLM $42.00
- SSY $1.91
- Technical
- Relative Strength Index (RSI)
- APLM 40.12
- SSY 49.06
- Support Level
- APLM $5.90
- SSY $0.85
- Resistance Level
- APLM $6.88
- SSY $1.07
- Average True Range (ATR)
- APLM 0.60
- SSY 0.07
- MACD
- APLM 0.01
- SSY 0.00
- Stochastic Oscillator
- APLM 13.17
- SSY 29.14
About APLM Apollomics Inc.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.